ABSTRACT
Pregnant travellers are often unaware of the various infections that can be acquired during travel and that pregnant people may be at increased risk of severe disease compared to their non-pregnant counterparts. Pregnant people often seek pre-travel counselling from their obstetrician or primary care physicians, who may not be well versed in travel medicine. This paper aims to provide information for maternity care providers regarding important travel-related food, water and mosquito-borne illnesses, including their prevention and treatment methods, equipping maternity care providers to confidently counsel prospective travellers during pregnancy.
Subject(s)
Maternal Health Services , Travel-Related Illness , Female , Humans , Pregnancy , Counseling , Prospective StudiesABSTRACT
Porous boron nitride (BN) nanorods, which were synthesized via a one-stage pyrolysis, exhibited excellent catalytic performance for organics' degradation via peroxymonosulfate (PMS) activation. The origin of the unexpected catalytic function of porous BN nanorods was proposed, in which non-radical oxidation driven by the defects on porous BN dominated the sulfamethoxazole degradation via the generation of singlet oxygen (1O2). The adsorption energy between PMS and BN was calculated via density functional theory (DFT), and the PMS activation kinetics were further investigated using an electrochemical methodology. The evolution of 1O2 was verified by electron spin resonance (ESR) and chemical scavenging experiments. The observed non-radical oxidation presented a high robustness in different water matrices, combined with a series of much less toxic intermediates. The used BN was easily regenerated by heating in air, in which the B-O bond was fully recovered. These findings provide new insights for BN as a non-metal catalyst for organics' degradation via PMS activation, in both theoretical and practical prospects.
ABSTRACT
Ruthenium (Ru) derivatives have less toxicity and higher water-solubility than cisplatin, giving them great potential as antitumor metallodrugs. In this study, zebrafish were employed as a whole-organism model to screen new Ru compounds for anti-cell proliferation activity. After soaking fish embryos in cisplatin and five Ru derivatives, [Ru(terpy)(bpy)Cl]Cl, [Ru(terpy)(dppz)OH(2)](ClO(4))(2), [Ru(terpy)(tMen)OH(2)](ClO(4))(2), [Ru(terpy)(Me(4)Phen)OH(2)](ClO(4))(2), and Ru(bpy)(2)Cl(2), only cisplatin and [Ru(terpy)(bpy)Cl]Cl-treated embryos displayed obvious phenotypic effects, such as fin-reduction. After further modification of [Ru(terpy)(bpy)Cl]Cl's main structure and the synthesis of two structurally related compounds, [Ru(terpy)(dcbpyH(2))Cl]Cl and [Ru(terpy)(dmbpy)Cl]Cl, only [Ru(terpy)(dmbpy)Cl]Cl exhibited fin-reduction phenotypes. TUNEL assays combined with immunostaining techniques revealed that treatment with cisplatin, [Ru(terpy)(bpy)Cl]Cl, and [Ru(terpy)(dmbpy)Cl]Cl led proliferating fin mesenchymal cells to undergo apoptosis and consequently caused fin-reduction phenotypes. Furthermore, [Ru(terpy)(bpy)Cl]Cl was able to activate the P53-dependent and independent pathways, and induced human hepatoma cells to undergo apoptosis. In summary, it was concluded that the zebrafish model was effective for the screening of phenotype-based antiproliferation metallodrugs.
